Tumor collection/processing under physioxia uncovers highly relevant signaling networks and drug sensitivity

B Kumar, AK Adebayo, M Prasad, ML Capitano… - Science …, 2022 - science.org
Preclinical studies of primary cancer cells are typically done after tumors are removed from
patients or animals at ambient atmospheric oxygen (O2,~ 21%). However, O2 …

Flower isoforms promote competitive growth in cancer

E Madan, CJ Pelham, M Nagane, TM Parker… - Nature, 2019 - nature.com
In humans, the adaptive immune system uses the exchange of information between cells to
detect and eliminate foreign or damaged cells; however, the removal of unwanted cells does …

Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis

N Marino, R German, X Rao, E Simpson, S Liu… - NPJ Breast …, 2020 - nature.com
Histologically normal tissue adjacent to the tumor can provide insight of the
microenvironmental alterations surrounding the cancerous lesion and affecting the …

Stromal heterogeneity may explain increased incidence of metaplastic breast cancer in women of African descent

B Kumar, AS Khatpe, J Guanglong, K Batic… - Nature …, 2023 - nature.com
The biologic basis of genetic ancestry-dependent variability in disease incidence and
outcome is just beginning to be explored. We recently reported enrichment of a population of …

TONSL is an immortalizing oncogene and a therapeutic target in breast cancer

AS Khatpe, R Dirks, P Bhat-Nakshatri, H Mang, K Batic… - Cancer research, 2023 - AACR
Study of genomic aberrations leading to immortalization of epithelial cells has been
technically challenging due to the lack of isogenic models. To address this, we used healthy …

FAM83A is a potential biomarker for breast cancer initiation

N Marino, R German, R Podicheti, P Rockey… - Biomarker …, 2022 - Springer
Background Family with sequence similarity 83 member A (FAM83A) presents oncogenic
properties in several cancers including breast cancer. Recently, we reported FAM83A …

Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone

S Liu, D Wu, X Sun, Y Fan, R Zha, A Jalali, Y Feng… - Bone research, 2021 - nature.com
Osteocytes are the most abundant cells in bone, which is a frequent site of breast cancer
metastasis. Here, we focused on Wnt signaling and evaluated tumor-osteocyte interactions …

LEFTY1 is a dual-SMAD inhibitor that promotes mammary progenitor growth and tumorigenesis

M Zabala, NA Lobo, J Antony, LS Heitink, GS Gulati… - Cell Stem Cell, 2020 - cell.com
SMAD pathways govern epithelial proliferation, and transforming growth factor β (TGF-β and
BMP signaling through SMAD members has distinct effects on mammary development and …

Breast cancer cell detection and characterization from breast milk–derived cells

P Bhat-Nakshatri, B Kumar, E Simpson, KK Ludwig… - Cancer research, 2020 - AACR
Radiologic techniques remain the main method for early detection for breast cancer and are
critical to achieve a favorable outcome from cancer. However, more sensitive detection …

[HTML][HTML] Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells

A Lamichhane, GD Luker, S Agarwal, H Tavana - Oncotarget, 2023 - ncbi.nlm.nih.gov
Drug resistance is a major barrier against successful treatments of cancer patients. Gain of
stemness under drug pressure is a major mechanism that renders treatments ineffective …